×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
JCR Pharmaceuticals Full Year 2024 Earnings: Misses Expectations
Simply Wall Street
JCR Pharmaceuticals ( TSE:4552 ) Full Year 2024 Results Key Financial Results Revenue: JP¥42.9b (up 25% from FY 2023...
5 days ago
Takeda's gene therapy pivot leaves JCR behind
Fierce Biotech
JCR Pharmaceuticals has achieved proof of concept for its gene therapy technology—just in time to lose partner Takeda as the pharma pivots...
4 months ago
JCR Pharma: Crossing Oceans And The Blood-Brain Barrier
invivo.citeline.com
After 45 years as a domestic Japanese biopharmaceutical company, JCR Pharmaceuticals is expanding into global markets. The company is betting that its...
6 months ago
JCR Pharmaceuticals doses first patient in MPS IIIA trial
Clinical Trials Arena
JCR Pharmaceuticals has dosed the first patient in the Phase I/II clinical trial of JR‑441 for the treatment of Mucopolysaccharidosis Type IIIA...
6 months ago
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative ...
Business Wire
JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with...
1 month ago
JCR Pharmaceuticals enters another deal with Alexion
The Pharma Letter
Under the terms of the accord, JCR and Alexion will research and develop oligonucleotide therapeutics using J-Brain Cargo Technology. As part of...
4 months ago
Hunter Syndrome Market to Register Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Look Out ...
Yahoo Finance
The dynamics of the Hunter syndrome market are anticipated to change in the coming years owing to the launch of emerging therapies and...
6 months ago
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
Business Wire
JCR Pharmaceuticals announced today that it will present six presentations at the 20th Annual WORLDSymposium 2024 in San Diego, Calif.
3 months ago
Healthcare brands, agencies and patients recognize Rare Disease Day 2024
Medical Marketing and Media
Pharma companies, healthcare brands and patient advocates took to the internet to raise awareness during Rare Disease Day 2024.
2 months ago
Takeda, JCR ink deal to commercialize Hunter syndrome drug in key markets
Fierce Pharma
Six months after gaining approval in Japan for its Hunter syndrome treatment Izcargo, JCR Pharmaceuticals has made a move to prepare for an...
31 months ago